CVRx (CVRX) Gains from Sales and Divestitures (2023 - 2026)
CVRx's Gains from Sales and Divestitures was -$1,000 in Q1 2026.
Powered by 
Analysis
CVRx (CVRX) Gains from Sales and Divestitures (2023 - 2026) Analysis & Trends
For FY2025, Gains from Sales and Divestitures at CVRx came in at -$86,000.
- In earlier years, Gains from Sales and Divestitures was -$4,000 in FY2023.
- The Q1 2026 figure marks the lowest quarterly Gains from Sales and Divestitures since Q1 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn |
| 10 | CVRx | 41.29 Mn | -256.43 Mn | 13.72 Mn |
API Access
CVRx Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=CVRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "CVRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=CVRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();